Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications 4
ID: 75N91021R00003 • Type: Solicitation
• Match:
90%
Opportunity Assistant
Loading
Overview
Response Deadline
Jan. 15, 2021, 4:00 p.m. EST (original: Jan. 4, 2021, 4:00 p.m. EST)
Past Due
Posted
Nov. 20, 2020, 5:53 p.m. EST (updated: Jan. 13, 2021, 12:33 p.m. EST)
Set Aside
None
Place of Performance
United States
Source
Current SBA Size Standard
1000 Employees
Pricing
Multiple Types Common
Est. Level of Competition
High
On 11/20/20 National Cancer Institute issued Solicitation 75N91021R00003 for Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications due 1/15/21.
The opportunity was issued full & open with NAICS 541715 and PSC AN12.
Primary Contact
Secondary Contact
Documents
Posted documents for Solicitation 75N91021R00003
Question & Answer
The AI Q&A Assistant has moved to the bottom right of the page
Opportunity Lifecycle
Procurement notices related to Solicitation 75N91021R00003
Award Notifications
Agency published notification of awards for Solicitation 75N91021R00003
IDV Awards
Indefinite delivery vehicles awarded through Solicitation 75N91021R00003
Incumbent or Similar Awards
Potential Bidders and Partners
Awardees that have won contracts similar to Solicitation 75N91021R00003
Similar Active Opportunities
Open contract opportunities similar to Solicitation 75N91021R00003
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NIH National Cancer Institute
FPDS Organization Code
7529-75NC00
Source Organization Code
500024179
Last Updated
Jan. 30, 2021
Last Updated By
randall.tiqui@nih.gov
Archive Date
Jan. 30, 2021